Skip to main content
Premium Trial:

Request an Annual Quote

MedArbor Diagnostics Gets FDA Emergency Use Authorization for COVID RT-PCR Test

NEW YORK – MedArbor Diagnostics has obtained Emergency Use Authorization from the US Food and Drug Administration for an RT-PCR assay to detect SARS-CoV-2, the virus that causes COVID-19, the agency said last week.

MedArbor Diagnostics is a full-service COLA- and CLIA-accredited clinical laboratory located near Philadelphia.

The MedArbor Diagnostics SARS-CoV-2 Assay is authorized for the qualitative detection of nucleic acid from SARS-CoV-2 in nasopharyngeal swab, oropharyngeal swab, anterior nasal swab, mid-turbinate nasal swab, nasopharyngeal wash/aspirate, and nasal aspirate specimens from individuals suspected of COVID-19 by their healthcare provider.

Emergency use of the test is limited to MedArbor's laboratory in Bristol, Pennsylvania, according to the FDA's authorization letter.

The Scan

ChatGPT Does As Well As Humans Answering Genetics Questions, Study Finds

Researchers in the European Journal of Human Genetics had ChatGPT answer genetics-related questions, finding it was about 68 percent accurate, but sometimes gave different answers to the same question.

Sequencing Analysis Examines Gene Regulatory Networks of Honeybee Soldier, Forager Brains

Researchers in Nature Ecology & Evolution find gene regulatory network differences between soldiers and foragers, suggesting bees can take on either role.

Analysis of Ashkenazi Jewish Cohort Uncovers New Genetic Loci Linked to Alzheimer's Disease

The study in Alzheimer's & Dementia highlighted known genes, but also novel ones with biological ties to Alzheimer's disease.

Tara Pacific Expedition Project Team Finds High Diversity Within Coral Reef Microbiome

In papers appearing in Nature Communications and elsewhere, the team reports on findings from the two-year excursion examining coral reefs.